Skip to main content
Premium Trial:

Request an Annual Quote

Phosphorus Gets NY Clinical Lab Permit, Test Approvals

NEW YORK (GenomeWeb) — Phosphorus announced today that it has received a clinical laboratory permit, as well as approvals for two of its next-generation sequencing-based diagnostics, from the New York State Department of Health (NYSDOH).

The lab-developed tests are designed to detect genetic variations — including SNPs, insertion-deletions, copy number variations, and variations in segmental duplications — in blood and saliva samples. Phosphorus said that one test screens for hereditary cancers and the other for arrhythmias, cardiomyopathies, and lipidemias.

With the NYSDOH molecular genetic testing permit, the New York City-based company will be able to offer the tests in New York state as well as throughout the US.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.